News: Molecular Biosciences

A new antibody design blocks cytomegalovirus from hiding from the immune system and could lead to safer, more effective treatments for vulnerable patients.

Tu-Quyen Dao, a senior biochemistry student, is studying how AI can be applied to improve healthcare.

The breakthrough could be used in a new vaccine or antibody therapy to fight mpox, the disease caused by the monkeypox virus.

Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA.

Could AI be the key to curing cancer? Meet the leader of a new research team putting that question to the test.

The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.

It was 84 years ago this week that UT researchers isolated and named folic acid.

Stengl-Wyer Endowment-supported researchers and research at UT Austin will explore life in a variety of forms and environments.

With support from the Cancer Prevention and Research Institute of Texas, molecular bioscientist Dima Kozakov joins UT.

UT Austin and Sanofi partner to build tool that predicts translation efficiency of mRNA sequences.